Roche’s POL7080 Polyphor Pact Signals Re-Entry Into Antibiotics R&D
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
By choosing Switzerland-based Polyphor’s investigational macrocycle antibiotic POL7080 for development and commercialization, Roche has given notice that it’s back in the antimicrobials space again.